EGF Theramed Health Corp. (TMED.CN) Research

EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to address various mental health challenges. The company's products are specifically utilized in the treatment of conditions such as intractable depression, anxiety disorders, post-traumatic stress disorder (PTSD), and general depression. Established in 2011, this firm operates from its main headquarters in Vancouver, Canada.

Market snapshot

Symbol
TMED.CN
Price
$0.07
Day change
-12.50%
Market cap
$890.9K
P/E ratio
-0.38x
52-week range
0.06-0.13
Sector
Healthcare
Industry
Medical - Healthcare Information Services

Peer companies

  • Captor Capital Corp. (CPTR.CN)
  • Copland Road Capital Corporation (CRCC.CN)
  • Entheon Biomedical Corp. (ENBI.CN)
  • Universal Ibogaine Inc. (IBO.V)
  • TripSitter Clinic Ltd. (KETA.CN)
  • Doseology Sciences Inc. (MOOD.CN)
  • Ovation Science Inc. (OVAT.CN)
  • Planet Based Foods Global Inc. (PBF.CN)

Open EGF Theramed Health Corp. (TMED.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.